# Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients

> **NCT01963663** · NA · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 84 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Metformin
- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT01963663
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-03
- **Final completion:** 2013-04
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2013-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01963663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01963663, "Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01963663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*